MeSH D014947 - wounds and injuries
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014947:Â
Wounds and injuries
D000007:Abdominal injuries
0 Companies
0 Drugs
Success rate
D000067390:Cold injury
0 Companies
0 Drugs
Success rate
D000067398:War-related injuries
0 Companies
0 Drugs
Success rate
D000070599:Shoulder injuries
0 Companies
0 Drugs
Success rate
D000070617:Physical microtrauma
0 Companies
0 Drugs
Success rate
D000071576:Crush injuries
0 Companies
0 Drugs
Success rate
D000072836:Surgical wound
0 Companies
0 Drugs
Success rate
D000081084:Accidental injuries
0 Companies
0 Drugs
Success rate
D000083102:Reinjuries
0 Companies
0 Drugs
Success rate
D000673:Traumatic amputation
0 Companies
0 Drugs
Success rate
D001134:Arm injuries
0 Companies
0 Drugs
Success rate
D001237:Asphyxia
0 Companies
0 Drugs
Success rate
D001265:Athletic injuries
0 Companies
0 Drugs
Success rate
D001469:Barotrauma
0 Companies
0 Drugs
Success rate
D001720:Birth injuries
0 Companies
0 Drugs
Success rate
D001733:Bites and stings
0 Companies
0 Drugs
Success rate
D002056:Burns
D004204:Joint dislocations
0 Companies
0 Drugs
Success rate
D004332:Drowning
0 Companies
0 Drugs
Success rate
D004556:Electric injuries
0 Companies
0 Drugs
Success rate
D004939:Esophageal perforation
0 Companies
0 Drugs
Success rate
D005119:Extravasation of diagnostic and therapeutic materials
D005547:Foreign bodies
0 Companies
0 Drugs
Success rate
D005627:Frostbite
0 Companies
0 Drugs
Success rate
D006230:Hand injuries
0 Companies
0 Drugs
Success rate
D007869:Leg injuries
0 Companies
0 Drugs
Success rate
D009104:Multiple trauma
0 Companies
0 Drugs
Success rate
D011832:Radiation injuries
D012188:Retropneumoperitoneum
0 Companies
0 Drugs
Success rate
D012421:Rupture
0 Companies
0 Drugs
Success rate
D012652:Self mutilation
0 Companies
0 Drugs
Success rate
D012774:Traumatic shock
0 Companies
0 Drugs
Success rate
D013119:Spinal cord injuries
D013708:Tendon injuries
0 Companies
0 Drugs
Success rate
D013898:Thoracic injuries
0 Companies
0 Drugs
Success rate
D014949:Nonpenetrating wounds
0 Companies
0 Drugs
Success rate
D014950:Penetrating wounds
D017695:Soft tissue injuries
0 Companies
0 Drugs
Success rate
D018058:Tympanic membrane perforation
0 Companies
0 Drugs
Success rate
D018677:Tooth injuries
0 Companies
0 Drugs
Success rate
D018882:Heat stress disorders
0 Companies
0 Drugs
Success rate
D019567:Back injuries
0 Companies
0 Drugs
Success rate
D019838:Neck injuries
0 Companies
0 Drugs
Success rate
D020196:Nervous system trauma
0 Companies
0 Drugs
Success rate
D022125:Lacerations
0 Companies
0 Drugs
Success rate
D025981:Hip injuries
0 Companies
0 Drugs
Success rate
D050723:Bone fractures
D056886:Contrecoup injury
0 Companies
0 Drugs
Success rate
D057772:Vascular system injuries
0 Companies
0 Drugs
Success rate
D060051:Occupational injuries
0 Companies
0 Drugs
Success rate
D061270:Nasal septal perforation
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Padagis | Bacitracin, Polymyxin b | Bacitracin Polymyxin B |  | 2002-02-27 |  |  |
| Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Bacitracin-neomycin-polymyxin W/ Hydrocortisone |  | 1982-01-01 |  |  | |
| Bacitracin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Bacitracin |  | 1982-01-01 |  |  | |
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1989-07-31 |  |  | |
| GSK | Polymyxin b | Aerosporin |  | 1982-01-01 |  |  |
| Neomycin, Polymyxin b | Neosporin |  | 1985-01-14 |  |  | |
| Bacitracin, Polymyxin b | Polysporin |  | 1985-03-01 |  |  | |
| Sandoz | Dexamethasone, Neomycin, Polymyxin b | Maxitrol |  | 1984-05-22 |  |  |
| Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone |  | 1983-08-25 |  |  | |
| Trimethoprim, Polymyxin b | Trimethoprim Polymyxin B |  | 1998-04-13 |  |  | |
| Novartis | Dexamethasone, Neomycin, Polymyxin b | Dexacidin |  | 1984-10-29 |  |  |
| Bausch Health Companies | Bacitracin, Polymyxin b | Bacitracin Polymyxin B |  | 1995-01-26 |  |  |
| Dexamethasone, Neomycin, Polymyxin b | Dexasporin |  | 1995-09-13 |  |  | |
| Bacitracin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Bacitracin |  | 1995-10-30 |  |  | |
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1994-07-25 |  |  | |
| Gramicidin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Gramicidin |  | 1996-01-31 |  |  | |
| Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone |  | 1995-12-29 |  |  | |
| Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates, Bacitracin Hydrocortisone |  | 1995-10-30 |  |  | |
| Hydrocortisone, Neomycin, Polymyxin b | Oticair |  | 1996-08-28 |  |  | |
| Trimethoprim, Polymyxin b | Trimethoprim Polymyxin B |  | 1997-02-14 |  |  | |
| Merck Sharp & Dohme | Hydrocortisone, Neomycin, Polymyxin b | Otobione |  | 1982-01-01 |  |  |
| Hydrocortisone, Polymyxin b | Otobiotic |  | 1982-01-01 |  |  | |
| Allergan | Prednisolone, Neomycin, Polymyxin b | Poly-pred |  | 1982-01-01 |  |  |
| Trimethoprim, Polymyxin b | Polytrim |  | 1988-10-20 |  |  | |
| Neomycin, Polymyxin b | Neomycin Polymyxin B |  | 1986-04-08 |  |  | |
| Gramicidin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Gramicidin |  | 1987-06-11 |  |  | |
| Hydrocortisone, Neomycin, Polymyxin b | Otocort |  | 1982-01-01 |  |  | |
| Pfizer | Chloramphenicol, Polymyxin b | Chloromyxin |  | 1982-01-01 |  |  |
| Oxytetracycline, Polymyxin b | Terramycin W/ Polymyxin |  | 1982-01-01 |  |  | |
| Oxytetracycline, Polymyxin b | Terramycin-polymyxin |  | 1982-01-01 |  |  | |
| Rising Pharmaceuticals | Polymyxin b | Polymyxin B |  | 2011-06-29 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
74%14/19
Phase 2
54%32/59
Phase 3
35%21/60
Approved: 2Overall Success rate: 14%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use